MFG
SAGE

Merit Financial Group’s Sage Therapeutics SAGE Stock Holding History

Merit Financial Group’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,876
Closed -$117K – 1850
2025
Q2 		$117K Buy
12,876
+1,907
+17% +$14K ﹤0.01% 1621
2025
Q1 		$87.2K Buy
+10,969
New +$80.3K ﹤0.01% 1359

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Merit Financial Group's SAGE Position: Q3 2025 in Review

Merit Financial Group sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 12,876 shares — an estimated $117K sold.

Merit Financial Group first reported a position in SAGE in Q1 2025 and held it in 2 quarters. The position peaked at $117K in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Merit Financial Group reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Merit Financial Group sold 12,876 Sage Therapeutics shares in Q3 2025, an estimated $117K.
  • Merit Financial Group first reported a position in Sage Therapeutics in Q1 2025 and held it in 2 quarters.
  • Merit Financial Group's Sage Therapeutics position peaked at $117K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Merit Financial Group's 13F filing for Q3 2025, filed 20 Oct 2025.